Organometallics
Article
since in all cases where this center of chirality did not exist
chiral information was poorly transferred to the reduced
ketones or imines.
NH), 4.0−3.7 (m, 2H, H9), 3.57 (m, 1H, H8), 3.04 (m, 1H, H8), 1.74
5
13
1
(
s, 15H, η -C (CH ) ). C{ H} NMR (100 MHz, CDCl ): δ 177.5
5
3
5
3
(
1
C7), 165.2 (C1), 136.3 (C6), 135.9 (C2), 131.5 (C5), 125.1 (C3),
5
5
22.0 (C4), 87.8 (η -C (CH ) ), 51.6 (C9), 45.1 (C8), 9.5 (η -
5 3 5
C (CH ) ).
5
3 5
+
EXPERIMENTAL SECTION
Analytical data for 7a: ES-MS: m/z (%) 527.20 (100) [M − Cl] .
■
Anal. Calcd for C H ClIrN ·1.5CH Cl : C, 42.67; H, 4.82; N, 4.06.
General Considerations. Experiments were carried out under
argon using a vacuum line and Schlenk techniques. Dichloromethane
and acetonitrile were distilled over calcium hydride under argon
immediately before use. Column chromatography was carried out on
Merck aluminum oxide 90 standardized. The following commercial
reagents were used as received: (2R,5R)-2,5-diphenylpyrrolidine,
sodium acetate, potassium hexafluorophosphate, 2-phenyl-2-imidazo-
line, sodium sulfate, cyclohexane, ethyl acetate, 2-propanol, acetophe-
none, potassium tert-butoxide, formic acid, and triethylamine. The
compounds listed hereafter were synthesized following reported
23 30
2
2
2
1
Found: C, 42.54; H, 4.82; N, 3.84. H NMR (500 MHz, CDCl ):
3
3
R ,R ,R diastereomer (76%), δ 7.78 (d, 1H, H6, J = 7.4), 7.21 (d,
C
C
Ir
3
3
3
1
5
3
1
2
H, H3, J = 7.4), 7.12 (t, 1H, H5, J = 7.4), 6.93 (t, 1H, H4, J = 7.3),
.53 (br, 1H, NH), 3.31 (ddd, 1H, H9, J = 14.2, J = 10.9, J = 3.1),
3
3
3
3
3
3
4
.06 (dddd, 1H, H8, J = 13.8, J = 10.9, J = 3.2, J = 3.0), 2.25 (dq,
2
3
2
3
H, CH , J = 12.0, J = 2.9), 2.06 (dq, 1H, CH , J = 11.1, J = 2.7),
2
2
5
.0−1.2 (m, 6H, CH ), 1.71 (s, 15H, η -C (CH ) ); R ,R ,S
2
5
3
5
C
C
Ir
3
diastereomer (24%), δ 7.90 (d, 1H, H6, J = 7.6), 7.21 (d, 1H, H3,
3
3
J = 7.4), 7.16 (t, 1H, H5, J = 7.5), 6.95 (m, 1H, H4), 5.64 (br, 1H,
29
3
3
3
NH), 3.45 (ddd, 1H, H9, J = 14.3, J = 11.0, J = 3.4), 3.38 (m, 1H,
procedures: [Cp*IrCl2]2 and [Cp*RhCl ] , (3aR,7aR)-2-phenyl-
2
2
3
0
2
3
2
H8), 2.44 (dq, 1H, CH , J = 11.6, J = 3.2), 2.12 (dq, 1H, CH , J =
3
a,4,5,6,7,7a-hexahydro-1H-benzo[d]imidazole (4), (4R,5R)-isoa-
2
2
3
1
32
3
5
1
1.6, J = 3.0), 2.0−1.2 (m, 6H, CH ), 1.74 (s, 15H, η -C (CH ) ).
marine (5), and N-phenyl-(1-phenylethylidene)amine. NMR
2
5
3 5
1
3
1
spectra were recorded at room temperature (unless otherwise stated)
C{ H} NMR (125 MHz, CDCl
3
): R ,R ,RIr diastereomer, δ 178.2
C C
1
on Bruker Avance spectrometers. H NMR spectra were recorded at
(C7), 164.9 (C1), 136.1 (C6), 135.1 (C2), 131.6 (C5), 124.7 (C3),
1
3
1
5
3
00.17, 400.13, or 500.13 MHz and referenced to SiMe4. C{ H}
NMR spectra (broad band decoupled) were recorded at 100.62,
25.77, or 150.92 MHz and referenced to SiMe . The NMR
121.4 (C4), 87.5 (η -C
29.9 (CH ), 25.0 (CH
diastereomer, δ 178.3 (C7), 165.3 (C1), 135.8 (C6), 135.3 (C2),
5
(CH
3 5 2
), 24.4 (CH
) ), 70.0 (C9), 68.2 (C8), 30.7 (CH ),
5
), 9.8 (η -C (CH ) ); R ,R ,SIr
2 5 3 5 C C
2
2
1
4
5
assignments were supported by 2D spectra: COSY, NOESY, and/or
131.3 (C5), 124.6 (C3), 121.5 (C4), 87.5 (η -C
66.2 (C8), 31.2 (CH ), 30.1 (CH ), 24.9 (CH ), 24.5 (CH
(CH ).
Compound 8a. To a solution of [Cp*IrCl
mmol) in CH Cl (10 mL) were added the imidazoline ligand 5 (75
5 3 5
(CH ) ), 71.6 (C9),
1
13
1
5
ROESY for H NMR and HSQC and HMBC for C{ H} NMR.
Chemical shifts are reported in ppm and coupling constants in Hz; the
latter are proton−proton coupling constants unless otherwise stated.
The 13C{ H} signals are singlets unless otherwise stated. For the
adopted numbering scheme, see Scheme 3. Multiplicity: s, singlet; d,
doublet; t, apparent triplet; q, apparent quartet; m, multiplet; br, broad
signal. ES-MS spectra and elemental analyses were carried out by the
2
2
2
), 10.0 (η -
2
C
)
3 5
5
] (100 mg, 0.126
2 2
1
2
2
mg, 0.25 mmol) and NaOAc (25 mg, 0.30 mmol). The reaction
mixture was stirred at room temperature for 4 h and then filtered over
Celite. The filtrate was washed with water (2 × 5 mL), dried over
anhydrous Na SO , and evaporated in vacuo. Compound 8a was
isolated as a yellow-orange powder (135 mg, 82% yield).
corresponding facilities at the Institut de Chimie, Universite
Strasbourg.
́
de
2 4
+
Compound 2a. To a solution of [Cp*IrCl2]2 (90 mg, 0.113
mmol) in CH Cl (9 mL) were added ligand 1 (50 mg, 0.226 mmol)
ES-MS: m/z (%) 625.21 (100) [M − Cl] . Anal. Calcd for
31
1
C
H
32ClIrN
· /
CH
Cl
: C, 55.07; H, 4.81; N, 4.11. Found: C, 55.22;
2
2
2
4
2
2
1
and NaOAc (24 mg, 0.293 mmol). The reaction mixture was stirred at
room temperature for 18 h, and then the resulting orange solution was
evaporated in vacuo. KPF (95 mg, 0.516 mmol) and CH CN (5 mL)
H, 4.98; N, 4.01. H NMR (400 MHz, CDCl ): R ,R ,RIr diastereomer
(64%), δ 7.81 (d, 1H, H6, J = 7.5), 7.52 (d, 2H, HPh ortho, J = 7.3),
3 C C
3
3
3
7.6−7.2 (m, 10H, H3 + H5 + HPh), 7.00 (t, 1H, H4, J = 7.5), 5.68 (br
6
3
3
3
3
were added. The reaction mixture was stirred at room temperature for
h and was then chromatographed over Celite and alumina using
CH CN as eluent. Compound 2a was isolated as a yellow solid after
d, 1H, NH, J = 2), 5.01 (d, 1H, H9, J = 11.3), 4.86 (dd, 1H, H8, J =
3
5
2
11.3, J = 2.1), 1.46 (s, 15H, η -C (CH ) ); R ,R ,SIr diastereomer
5 3 5 C C
3
3
(36%), δ 7.86 (d, 1H, H6, J = 7.7), 7.46 (d, 2H, HPh ortho, J = 7.5),
3
3
recrystallization in CH Cl /pentane (111 mg, 67% yield).
7.6−7.2 (m, 10H, H3 + H5 + HPh), 7.03 (t, 1H, H4, J = 7.5), 5.48 (br,
2
2
3
3
Mp: 78 °C dec. Anal. Calcd for C H F IrN P: C, 45.71; H, 4.66;
1H, NH), 5.14 (d, 1H, H9, J = 5.5), 4.71 (d, 1H, H8, J = 5.6), 1.44
2
8
34
6
2
5
13
1
N, 3.81. Found: C, 46.39; H, 5.05; N, 3.77.
Compound 2b. To a solution of [Cp*RhCl ] (70 mg, 0.113
(s, 15H, η -C (CH ) ). C{ H} NMR (150 MHz, CDCl ): R ,R ,RIr
5 3 5 3 C C
diastereomer, δ 177.6 (C7), 165.6 (C1), 140.1 (CPh ipso), 139.3
(CPh ipso), 136.0 (C6), 134.2 (C2), 132.5 (C5), 129.0 (CHPh), 128.9
2
2
mmol) in CH Cl (9 mL) were added ligand 1 (50 mg, 0.226 mmol)
2
2
and NaOAc (24 mg, 0.293 mmol). The reaction mixture was stirred at
room temperature for 18 h, and then the resulting red-orange solution
was evaporated in vacuo. KPF (95 mg, 0.516 mmol) and CH CN (5
(CHPh), 128.6 (CHPh), 128.3 (CHPh), 128.2 (CHPh), 127.4 (CHPh),
5
124.7 (C3), 121.6 (C4), 87.5 (η -C
(CH
)
), 79.7 (C9), 72.2 (C8),
5
5
3
5
9.3 (η -C (CH ) ); R ,R ,SIr diastereomer, δ 176.7 (C7), 164.6 (C1),
6
3
5 3 5 C C
mL) were added. The reaction mixture was stirred at room
temperature for 2 h and was then chromatographed over Celite and
143.7 (CPh ipso), 142.0 (CPh ipso), 136.3 (C6), 135.0 (C2), 131.5 (C5),
129.1 (CH ), 129.0 (CH ), 128.7 (CH ), 128.2 (CH ), 127.8
Ph
Ph
Ph
Ph
5
alumina using CH CN as eluent. Compound 2b was isolated as an
(CH ), 127.5 (CH ), 124.8 (C3), 121.7 (C4), 88.0 (η -C (CH ) ),
3
Ph Ph 5 3 5
5
orange solid after recrystallization in CH Cl /pentane (103 mg, 71%
79.5 (C9), 72.5 (C8), 9.5 (η -C (CH ) ).
5 3 5
2
2
yield).
Mp: 100 °C dec. Anal. Calcd for C H F N PRh· / CH Cl : C,
Compounds 6b and 7b. To a solution of [Cp*RhCl ] (300 mg,
2 2
1
0.485 mmol) in CH Cl (30 mL) were added the imidazoline ligand
28
34
6
2
3
2
2
2
2
5
0.43; H, 5.18; N, 4.15. Found: C, 50.08; H, 5.41; N, 4.09.
Compounds 6a and 7a. To a solution of [Cp*IrCl ] (300 mg,
(0.970 mmol; 3, 142 mg; 4, 194 mg) and NaOAc (98 mg, 1.19 mmol).
The reaction mixture was stirred at room temperature for 4 h and then
filtered over Celite. The filtrate was washed with water (2 × 50 mL),
dried over anhydrous Na SO , and evaporated in vacuo. The
2
2
0
.377 mmol) in CH Cl (30 mL) was added the imidazoline ligand
2
2
(
0.750 mmol; 3: 110 mg, 4: 150 mg) and NaOAc (74 mg, 0.90 mmol).
2
4
The reaction mixture was stirred at room temperature for 4 h and then
compounds were isolated as red powders (6b, 190 mg, 47% yield;
7b, 230 mg, 50% yield).
filtered over Celite. The filtrate was washed with water (2 × 50 mL),
dried over anhydrous Na SO4 and evaporated in vacuo. The
Analytical data for 6b: Mp: > 250 °C dec. ES-MS: m/z (%) 383.10
2
+
compounds were isolated as yellow-orange powders (6a: 167 mg,
(100) [M − Cl] . Anal. Calcd for C H ClN Rh: C, 54.49; H, 5.77;
19
24
2
1
4
4% yield; 7a: 294 mg, 70% yield).
N, 6.68. Found: C, 54.13; H, 5.88; N, 6.61. H NMR (500 MHz,
CDCl ): δ 7.80 (d, 1H, H6, J = 7.5), 7.30 (d, 1H, H3, J = 7.5), 7.20
(t, 1H, H5, J = 7.5), 6.98 (t, 1H, H4, J = 7.4), 6.08 (br, 1H, NH),
3
3
Analytical data for 6a: Mp: > 250 °C dec. ES-MS: m/z (%) 473.15
3
+
1
3
3
(
100) [M − Cl] . Anal. Calcd for C H ClIrN · / CH Cl : C, 43.29;
19
24
2
3
2
2
1
H, 4.64; N, 5.22. Found: C, 43.46; H, 4.85; N, 4.76. H NMR (300
3.91 (m, 1H, H9), 3.74 (m, 1H, H9), 3.41 (m, 1H, H8), 2.63 (m, 1H,
3
3
5
13
1
MHz, CDCl ): δ 7.80 (d, 1H, H6, J = 7.5), 7.30 (d, 1H, H3, J = 7.5),
H8), 1.65 (s, 15H, η -C (CH ) ). C{ H} NMR (125 MHz, CDCl ):
3
5
3
5
3
3
3
1
2
7.15 (t, 1H, H5, J = 7.5), 6.94 (t, 1H, H4, J = 7.5), 5.79 (br, 1H,
δ 178.9 (d, C1, J = 32), 172.7 (d, C7, J = 3), 136.5 (C6), 135.5
CRh
CRh
dx.doi.org/10.1021/om400626m | Organometallics XXXX, XXX, XXX−XXX
G